ArticleScientific reports2025

Glycolysis-related MiRNA signature predicts prognosis, recurrence risk, and therapeutic responses in hepatocellular carcinoma.

Guomiao Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.